• ETF
  • Nippon India Nifty Pharma ETF (G)
Nippon India Nifty Pharma ETF (G)

Nippon India Nifty Pharma ETF (G)

EquityIndex Funds 
  • 21.5893

    NAV

  • 1.6%

    Change

Nippon India Nifty Pharma ETF (G) NAV

21.5893

NAV (Mar 19)

Nippon India Nifty Pharma ETF (G) returns

Last 1Y
12.2%
Last 3Y
16.4%
Last 5Y
-
Last 10Y
-
Since Inception
11.1%
6 Month CAGR
-8.5%
info-icon-blue

Nippon India Nifty Pharma ETF (G) Information

Investment Objective

The scheme seeks to provide investment returns closely corresponding to the total returns of the securities as represented by the NIFTY Pharma Index before expenses, subject to tracking errors.

Expense Ratio
0.21%
Launched (3Y ago)
2021-07-02
AUM in Crores
809.2
ISIN
INF204KC1089
Lock-in
No Lock-in
Benchmark
NIFTY Pharma Total Return Index
SIP Minimum
1000
Lumpsum Min.
5000

Fund Managers

user-avatar

Himanshu Mange

Fund Manager

user-avatar

Jitendra Tolani

Fund Manager

Explore reliance nippon life Mutual Funds

Fund Name
Till Date CAGR
reliance-nippon-life
Nippon India Arbitrage Fund Direct (G)

7.2%

7.1%

6.4%

6.9%

7.5%

8.7%

7.9%

9%

18.7%

16%

Compare similar ETF's

Fund Name
Till Date CAGR

18.4%

7.8%

18.1%

10.7%

6.7%

7.5%

6.7%

5.9%

5.9%

5.5%

Asset allocation and Holdings

Last updated on 2025-03-12

Top 10 Stock Holdings

Sun Pharmaceutical Industries Ltd.
24.6 %
Dr. Reddy's Laboratories Ltd.
10.9 %
Cipla Ltd.
10.8 %
Divi's Laboratories Ltd.
8.3 %
Lupin Ltd.
6.1 %
Aurobindo Pharma Ltd.
5.4 %
Zydus Lifesciences Ltd.
4.2 %
Torrent Pharmaceuticals Ltd.
3.9 %
Alkem Laboratories Ltd.
3.5 %
Glenmark Pharmaceuticals Ltd.
2.9 %
See all holdings

Compare ETFs

vs
for

Nippon India Nifty Pharma ETF (G) Review

Nippon India Nifty Pharma ETF (G) is an Exchange Traded Fund which is benchmarked to . Nippon India Nifty Pharma ETF (G) is managed by the Nippon India Mutual Fund with the fund managers being Himanshu Mange, Jitendra Tolani. The Nippon India Nifty Pharma ETF (G) was launched on 2021-07-02 with no lock-in period. Since its inception, the fund has delivered 11.086% as a return on investment.The fund has delivered a 1-year return of 12.247%, a 3-year return of 16.386%.

As on 19 Mar, 2025 the NAV of the fund is Rs 21.59 and the AUM is Rs 809.18 crores. The fund charges an expense ratio of 0.21% on an annual basis. You can start a SIP with an investment of a minimum of Rs 100. You can make a lumpsum investment of minimum of Rs 5000.

Since the scheme is benchmarked to , the fund is subject to very high risk and it may witness volatility in the short term. Hence, an exchange-traded fund is more suitable for an investment horizon of more than 5 years. The Nippon India Nifty Pharma ETF (G) has an asset allocation of 0% in equity and equity equivalents and 0% in debt securities.

Scripbox provides a unique feature through which you can compare the performance of Nippon India Nifty Pharma ETF (G) with another fund in a similar category. This way you can make a well-informed investment decision.